Gordon Tatman v. Marvin Williams, Valley Proteins, inc.and Travelers Indemnity Ins. Co.

Louisiana Court of Appeal·Decided December 6, 2023·No. CA-0023-0136·Unknown

Opinion

NOT DESIGNATED FOR PUBLICATION

STATE OF LOUISIANA

COURT OF APPEAL, THIRD CIRCUIT

23-136

GORDON TATMAN VERSUS

MARVIN WILLIAMS, VALLEY PROTEINS, INC. AND TRAVELERS INDEMNITY INSURANCE COMPANY

**********

APPEAL FROM THE

TWENTY-SEVENTH JUDICIAL DISTRICT COURT PARISH OF ST. LANDRY, NO. 18-C-4006-D HONORABLE D. JASON MECHE, DISTRICT JUDGE

**********

SHARON DARVILLE WILSON

JUDGE

**********

Court composed of D. Kent Savoie, Van H. Kyzar, and Sharon Darville Wilson, Judges.

AFFIRMED.

Pride J. Doran Quincy L. Cawthorne Adrian P. Smith DORAN & CAWTHORNE, P.L.L.C. Post Office Box 2119 Opelousas, Louisiana 70571 (337) 948-8008 COUNSEL FOR PLAINTIFF/APPELLANT:

Gordon Tatman

Thear J. Lemoine John J. Elmer, Jr. BROWN SIMS, P.C. 365 Canal Street, 29th Floor New Orleans, Louisiana 70163 (504) 569-1007 COUNSEL FOR DEFENDANTS/APPELLEES:

Travelers Indemnity Insurance Company Marvin Williams Valley Proteins, Inc.

WILSON, Judge.

Plaintiff, Gordon Tatman, appeals the judgment of the trial court finding defendants, Marvin Williams, Valley Proteins, Inc., and Travelers Indemnity Insurance Company, solely at fault for his injuries following an automobile accident, but awarding him only $65,000 in general damages and denying all future medical expenses. For the reasons expressed below, we affirm the judgment of the trial court.

I.

ISSUES

In this appeal we must decide:

(1) whether the trial court erred in denying Appellant, Gordon Tatman, an award for future medical treatment, based solely on its finding that Gordon Tatman was not a credible witness, and not on the record as a whole; and

(2) whether the trial court erred in awarding Appellant, Gordon Tatman, only $65,000 for general damages and $0.00 for future medical treatment.

II.

FACTS AND PROCEDURAL HISTORY On September 11, 2017, Mr. Tatman was a passenger in a Honda Civic driven by his friend, David Papillion. Marvin Williams was the operator of a large commercial truck as a part of his employment with Valley Proteins, Inc. and was insured by Travelers Indemnity Insurance Company. While crossing Louisiana Highway 10 to merge onto Interstate 49, Mr. Williams failed to yield at a stop sign and collided with the Honda Civic, causing personal injuries to Mr. Tatman.

After the accident, Mr. Tatman sought treatment from Metropolitan Health Group (Metro) on September 12, 2017, and reported a history of prior lower back pain. Mr. Tatman continued receiving treatment from Metro throughout

September. On September 26, 2017, Mr. Tatman rear-ended a vehicle after leaving a physical therapy session at Metro. At some other point in the month, a police car rammed Mr. Tatman’s vehicle.

Mr. Tatman began seeing an orthopedic surgeon, Dr. George Raymond Williams, on September 28, 2017, where he denied having any preexisting musculoskeletal afflictions. Mr. Tatman underwent an MRI of his lumbar and cervical spine on October 12, 2017. The lumbar MRI revealed posterior disc bulges at the L2-3, L3-4, L4-5, L5-S1 levels of the spine, with bilateral foraminal stenosis at the L3-4 and L5-S1. The cervical MRI revealed severe foraminal stenosis at the C2-3 levels of the spine, mild stenosis at the C5-6 level, and mild to moderate foraminal stenosis at the C7-T1. On December 5, 2017, Mr. Tatman underwent MRIs on his left shoulder, left knee and right ankle.

On January 29, 2018, Mr. Tatman began seeing Dr. Steven Wyble for pain management. At a June 21, 2018 visit, Mr. Tatman tested positive for benzodiazepines, opiates, oxycodone, and marijuana on a drug screen. On July 2, 2018, Mr. Tatman started physical therapy at Recovery ChiroMed. He attended a total of eleven visits before discontinuing treatment on September 5, 2018. On August 29, 2018, Mr. Tatman filed his petition for damages naming the driver, Marvin Williams, his employer, and their insurer as defendants.

In September 2018, Mr. Tatman was incarcerated and remained in custody until June 2019. While incarcerated, Mr. Tatman continued to treat with Dr. Williams on February 7, 2019, March 25, 2019, and May 14, 2019. On September 16, 2019, Mr. Tatman presented to Dr. Joseph Gillespie for pain management and had a second visit with him on October 14, 2019. On October 30, 2019, a neurosurgeon, Dr. Najeeb Thomas, performed an independent medical examination

of Mr. Tatman in which Mr. Tatman gave him a history. Dr. Thomas conducted a physical examination and reviewed his prior MRIs.

On November 24, 2019, Mr. Tatman was hospitalized and described as homicidal with paranoid delusions. He was brought to the hospital under an involuntary outpatient commitment for a history of bipolar disorder, schizophrenia, suicidal thoughts, and danger to others. He also tested positive for phencyclidine (PCP), cannabinoids, and benzodiazepines. On December 3, 2019, Mr. Tatman returned to Metro for a single isolated visit. From this date until April 26, 2022, there was no documented medical treatment. During this period, Mr. Tatman was again incarcerated. While incarcerated, Mr. Tatman wrote a letter to Judge Caswell indicating he suffered from a drug problem and had been in four physical altercations.

On April 26, 2022, Dr. Williams’s office recommended that Mr.

Tatman go back to physical therapy and pain management and that he would consider repeat MRIs of the cervical spine, lumbar spine, and left knee if they failed. On June 14, 2022, after attending two physical therapy sessions, Dr. Williams recommended Mr. Tatman undergo a robotic surgery and new MRIs would be necessary.

Trial commenced on July 25, 2022. The trial court was presented with the deposition testimony of Dr. Williams and Dr. Thomas and heard live testimony from David Papillion, Mr. Tatman, and Mr. Tatman’s mother. Trial concluded on July 26, 2022. On September 26, 2022, the trial court signed reasons for judgment and a final judgment was rendered on November 22, 2022. In its reasons for judgment, the trial court noted that due to Mr. Tatman’s “numerous credibility issues, the court finds he failed to prove the need for any future medical treatment. Thus, the court does not award any future medical expenses.” The trial court ruled

in favor of Mr. Tatman and against defendants awarding him $19,234.20 for past medical expenses and $65,000 for general damages. Mr. Tatman now appeals.

III.

STANDARD OF REVIEW

On appeal, Mr. Tatman contends that the trial court erred in denying him any future medical expenses and only awarding $65,000 in general damages. Future medical expenses are items of special damages. Armentor v. Safeway Ins. Co., 07-805 (La.App. 3 Cir. 12/19/07), 972 So.2d 444. It is well settled that a factfinder is afforded great discretion in its determination of both general and special damages and a reviewing court will not set aside such awards in the absence of manifest error. Baack v. McIntosh, 20-1054 (La. 6/30/21), 333 So.3d 1206. Moreover, when the findings are based on credibility determinations, the manifest error standard demands that great deference be given to the trier of fact’s findings because only the fact finder can be aware of the variations in demeanor and tone of voice which weigh heavily on the listeners belief in what is said by the witness. Rosell v. ESCO, 549 So.2d 840 (La.1989).

IV.

LAW AND DISCUSSION

Future Medical Expenses In his first assignment of error, Mr. Tatman contends that the trial court erred in denying him an award for future medical treatment, based solely on its finding that he was not a credible witness, and not on the record as a whole. We disagree with Mr. Tatman’s contention. Mr. Tatman specifically points to the trial court’s written reasons for judgment wherein it states, “Due to Tatman’s numerous credibility issues, the court finds he failed to prove the need for any future medical treatment. Thus, the court does not award any future medical expenses.”

Free access — add to your briefcase to read the full text and ask questions with AI

Gordon Tatman v. Marvin Williams, Valley Proteins, inc.and Travelers Indemnity Ins. Co., (La. Ct. App. 2023).

Gordon Tatman v. Marvin Williams, Valley Proteins, inc.and Travelers Indemnity Ins. Co. (Gordon Tatman v. Marvin Williams, Valley Proteins, inc.and Travelers Indemnity Ins. Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Menard v. Lafayette Insurance Co.
31 So. 3d 996 (Supreme Court of Louisiana, 2010)
Armentor v. Safeway Ins. Co.
972 So. 2d 444 (Louisiana Court of Appeal, 2007)
Youn v. Maritime Overseas Corp.
623 So. 2d 1257 (Supreme Court of Louisiana, 1993)
Davis v. Sonnier
682 So. 2d 910 (Louisiana Court of Appeal, 1996)
Duncan v. Kansas City Southern Railway Co.
773 So. 2d 670 (Supreme Court of Louisiana, 2000)
Rosell v. Esco
549 So. 2d 840 (Supreme Court of Louisiana, 1989)
McCray v. Delta Industries, Inc.
809 So. 2d 265 (Louisiana Court of Appeal, 2001)
Coco v. Winston Industries, Inc.
341 So. 2d 332 (Supreme Court of Louisiana, 1977)
Longoria v. Brookshire Grocery Co.
862 So. 2d 1172 (Louisiana Court of Appeal, 2003)
Reck v. Stevens
373 So. 2d 498 (Supreme Court of Louisiana, 1979)
Guillory v. Saucier
79 So. 3d 1188 (Louisiana Court of Appeal, 2011)
LADAY v. Doe
59 So. 3d 516 (Louisiana Court of Appeal, 2011)
Howard v. Union Carbide Corp.
50 So. 3d 1251 (Supreme Court of Louisiana, 2010)
Wooley v. Lucksinger
61 So. 3d 507 (Supreme Court of Louisiana, 2011)